Roche immunotherapy drug shrinks tumors in early bladder cancer study

ZURICH (Reuters) - Roche's experimental drug that spurs the immune system to fight cancer shrank tumors in 43 percent of people with a specific type of metastatic bladder cancer, according to results of an early-stage trial published on Saturday.

via Reuters: Health News Read More Here..